{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:19:38Z","timestamp":1794277178034,"version":"4.9.0"},"reference-count":276,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-025-10265-3","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T09:55:49Z","timestamp":1746266149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Molecular mechanisms of metastatic peritoneal dissemination in gastric adenocarcinoma"],"prefix":"10.1007","volume":"44","author":[{"given":"Deanna","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahima","family":"Dossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Swallow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karineh","family":"Kazazian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"issue":"3","key":"10265_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I., & Blanpain, C. (2019). EMT transition states during tumor progression and metastasis. Trends in Cell Biology, 29(3), 212\u2013226.","journal-title":"Trends in Cell Biology"},{"issue":"3","key":"10265_CR2","first-page":"889","volume":"61","author":"Y Hippo","year":"2001","unstructured":"Hippo, Y., et al. (2001). Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Research, 61(3), 889\u2013895.","journal-title":"Cancer Research"},{"issue":"2","key":"10265_CR3","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.4238\/2012.June.25.1","volume":"11","author":"FH Bai","year":"2012","unstructured":"Bai, F. H., et al. (2012). Screening and identification of peritoneal metastasis-related genes of gastric adenocarcinoma using a cDNA microarray. Genetics & Molecular Research, 11(2), 1682\u20131689.","journal-title":"Genetics & Molecular Research"},{"issue":"30","key":"10265_CR4","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.3748\/wjg.v22.i30.6829","volume":"22","author":"M Kanda","year":"2016","unstructured":"Kanda, M., & Kodera, Y. (2016). Molecular mechanisms of peritoneal dissemination in gastric cancer. World Journal of Gastroenterology, 22(30), 6829\u20136840.","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"10265_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10120-019-00978-0","volume":"23","author":"B Rau","year":"2020","unstructured":"Rau, B., et al. (2020). Peritoneal metastasis in gastric cancer: Results from the German database. Gastric Cancer, 23(1), 11\u201322.","journal-title":"Gastric Cancer"},{"issue":"4","key":"10265_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s10120-021-01160-1","volume":"24","author":"WJ Koemans","year":"2021","unstructured":"Koemans, W. J., et al. (2021). Synchronous peritoneal metastases of gastric cancer origin: Incidence, treatment and survival of a nationwide Dutch cohort. Gastric Cancer, 24(4), 800\u2013809.","journal-title":"Gastric Cancer"},{"issue":"4","key":"10265_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41416-023-02338-3","volume":"129","author":"JE Lee","year":"2023","unstructured":"Lee, J. E., et al. (2023). Genomic and evolutionary characteristics of metastatic gastric cancer by routes. British Journal of Cancer, 129(4), 672\u2013682.","journal-title":"British Journal of Cancer"},{"key":"10265_CR8","doi-asserted-by":"crossref","unstructured":"Ren, K., et al., Development of the peritoneal metastasis: A review of back-grounds, mechanisms, treatments and prospects. J Clin Med, 2022. 12(1).","DOI":"10.3390\/jcm12010103"},{"key":"10265_CR9","doi-asserted-by":"crossref","unstructured":"Yonemura, Y., et al., The development of peritoneal metastasis from gastric cancer and rationale of treatment according to the mechanism. J Clin Med, 2022. 11(2).","DOI":"10.3390\/jcm11020458"},{"issue":"5","key":"10265_CR10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu, R., et al. (2015). Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nature Medicine, 21(5), 449\u2013456.","journal-title":"Nature Medicine"},{"issue":"6","key":"10265_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s10620-006-9570-x","volume":"52","author":"F Bai","year":"2007","unstructured":"Bai, F., et al. (2007). Establishment and characterization of a high metastatic potential in the peritoneum for human gastric cancer by orthotopic tumor cell implantation. Digestive Diseases and Sciences, 52(6), 1571\u20131578.","journal-title":"Digestive Diseases and Sciences"},{"issue":"1","key":"10265_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gutjnl-2018-318070","volume":"69","author":"R Wang","year":"2020","unstructured":"Wang, R., et al. (2020). Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut, 69(1), 18\u201331.","journal-title":"Gut"},{"issue":"6","key":"10265_CR13","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s10620-006-9570-x","volume":"52","author":"F Bai","year":"2007","unstructured":"Bai, F., et al. (2007). Establishment and characterization of a high metastatic potential in the peritoneum for human gastric cancer by orthotopic tumor cell implantation. Digestive Diseases & Sciences, 52(6), 1571\u20131578.","journal-title":"Digestive Diseases & Sciences"},{"issue":"21","key":"10265_CR14","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.7150\/jca.25469","volume":"9","author":"F Li","year":"2018","unstructured":"Li, F., et al. (2018). S100A4-MYH9 axis promote migration and invasion of gastric cancer cells by inducing TGF-beta-mediated epithelial-mesenchymal transition. Journal of Cancer, 9(21), 3839\u20133849.","journal-title":"Journal of Cancer"},{"issue":"11","key":"10265_CR15","first-page":"4234","volume":"6","author":"Y Yonemura","year":"2000","unstructured":"Yonemura, Y., et al. (2000). Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clinical Cancer Research, 6(11), 4234\u20134242.","journal-title":"Clinical Cancer Research"},{"key":"10265_CR16","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.omtn.2021.02.003","volume":"23","author":"T Pan","year":"2021","unstructured":"Pan, T., et al. (2021). Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription. Mol Ther Nucleic Acids, 23, 1288\u20131303.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10265_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/carcin\/bgu232","volume":"36","author":"J Kurashige","year":"2015","unstructured":"Kurashige, J., et al. (2015). Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer. Carcinogenesis, 36(1), 133\u2013141.","journal-title":"Carcinogenesis"},{"key":"10265_CR18","doi-asserted-by":"crossref","unstructured":"Jiang, T., et al., FNDC1 promotes the invasiveness of gastric cancer via Wnt\/beta-catenin signaling pathway and correlates with peritoneal metastasis and prognosis. Frontiers in Oncology, 2020. 10 (no pagination).","DOI":"10.3389\/fonc.2020.590492"},{"issue":"2","key":"10265_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.21873\/anticanres.14812","volume":"41","author":"M Sasahara","year":"2021","unstructured":"Sasahara, M., et al. (2021). Tissue RNFT2 expression levels are associated with peritoneal recurrence and poor prognosis in gastric cancer. Anticancer Research, 41(2), 609\u2013617.","journal-title":"Anticancer Research"},{"issue":"7","key":"10265_CR20","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1245\/s10434-018-6480-z","volume":"25","author":"K Sawaki","year":"2018","unstructured":"Sawaki, K., et al. (2018). Troponin I2 as a specific biomarker for prediction of peritoneal metastasis in gastric cancer. Annals of Surgical Oncology, 25(7), 2083\u20132090.","journal-title":"Annals of Surgical Oncology"},{"issue":"5","key":"10265_CR21","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1097\/SLA.0000000000003647","volume":"274","author":"T Shimura","year":"2021","unstructured":"Shimura, T., et al. (2021). Genomewide expression profiling identifies a novel miRNA-based signature for the detection of peritoneal metastasis in patients with gastric cancer. Annals of Surgery, 274(5), e425\u2013e434.","journal-title":"Annals of Surgery"},{"issue":"11","key":"10265_CR22","doi-asserted-by":"publisher","first-page":"e112908","DOI":"10.1371\/journal.pone.0112908","volume":"9","author":"M Zang","year":"2014","unstructured":"Zang, M., et al. (2014). CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K\/AKT signaling pathway. PLoS ONE, 9(11), e112908.","journal-title":"PLoS ONE"},{"issue":"5","key":"10265_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000508350","volume":"87","author":"Y Takei","year":"2020","unstructured":"Takei, Y., et al. (2020). Long noncoding RNA HOTAIR promotes epithelial-mesenchymal transition and is a suitable target to inhibit peritoneal dissemination in human scirrhous gastric cancers. Pathobiology, 87(5), 277\u2013290.","journal-title":"Pathobiology"},{"issue":"5","key":"10265_CR24","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10120-019-00934-y","volume":"22","author":"Z Yu","year":"2019","unstructured":"Yu, Z., et al. (2019). Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M. Gastric Cancer, 22(5), 955\u2013966.","journal-title":"Gastric Cancer"},{"issue":"4","key":"10265_CR25","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1111\/jcmm.16217","volume":"25","author":"X Wang","year":"2021","unstructured":"Wang, X., et al. (2021). Piezo type mechanosensitive ion channel component 1 facilitates gastric cancer omentum metastasis. Journal of Cellular & Molecular Medicine, 25(4), 2238\u20132253.","journal-title":"Journal of Cellular & Molecular Medicine"},{"issue":"4","key":"10265_CR26","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1111\/jcmm.16217","volume":"25","author":"X Wang","year":"2021","unstructured":"Wang, X., et al. (2021). Piezo type mechanosensitive ion channel component 1 facilitates gastric cancer omentum metastasis. Journal of Cellular and Molecular Medicine, 25(4), 2238\u20132253.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"18","key":"10265_CR27","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.3748\/wjg.v20.i18.5403","volume":"20","author":"Z Peng","year":"2014","unstructured":"Peng, Z., et al. (2014). Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World Journal of Gastroenterology, 20(18), 5403\u20135410.","journal-title":"World Journal of Gastroenterology"},{"issue":"9","key":"10265_CR28","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3727\/096504017X14886494526344","volume":"25","author":"DZ Zhang","year":"2017","unstructured":"Zhang, D. Z., et al. (2017). Basic transcription factor 3 is required for proliferation and epithelial-mesenchymal transition via regulation of FOXM1 and JAK2\/STAT3 signaling in gastric cancer. Oncology Research, 25(9), 1453\u20131462.","journal-title":"Oncology Research"},{"issue":"13","key":"10265_CR29","doi-asserted-by":"publisher","first-page":"20741","DOI":"10.18632\/oncotarget.15119","volume":"8","author":"X Wu","year":"2017","unstructured":"Wu, X., et al. (2017). IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2\/STAT3 signaling pathway. Oncotarget, 8(13), 20741\u201320750.","journal-title":"Oncotarget"},{"issue":"4","key":"10265_CR30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1365-2559.2009.03247.x","volume":"54","author":"MA Kim","year":"2009","unstructured":"Kim, M. A., et al. (2009). Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology, 54(4), 442\u2013451.","journal-title":"Histopathology"},{"issue":"2","key":"10265_CR31","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1096\/fj.201901372RR","volume":"34","author":"Q Ge","year":"2020","unstructured":"Ge, Q., et al. (2020). Zic1 suppresses gastric cancer metastasis by regulating Wnt\/\u03b2-catenin signaling and epithelial-mesenchymal transition. The FASEB Journal, 34(2), 2161\u20132172.","journal-title":"The FASEB Journal"},{"issue":"12","key":"10265_CR32","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1111\/jcmm.13258","volume":"21","author":"S Wu","year":"2017","unstructured":"Wu, S., et al. (2017). AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression. Journal of Cellular and Molecular Medicine, 21(12), 3481\u20133493.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"38","key":"10265_CR33","doi-asserted-by":"publisher","first-page":"61021","DOI":"10.18632\/oncotarget.10477","volume":"7","author":"A Carino","year":"2016","unstructured":"Carino, A., et al. (2016). The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines. Oncotarget, 7(38), 61021\u201361035.","journal-title":"Oncotarget"},{"key":"10265_CR34","doi-asserted-by":"crossref","unstructured":"Toiyama, Y., et al., Use of co-expression of HGF and c-Met to predict peritoneal dissemination established by autocrine HGF\/c-Met signaling in gastric cancer. Journal of Clinical Oncology. Conference, 2011. 29(4 SUPPL. 1).","DOI":"10.1200\/jco.2011.29.4_suppl.40"},{"issue":"7","key":"10265_CR35","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/s41388-019-1078-x","volume":"39","author":"Q Zhou","year":"2020","unstructured":"Zhou, Q., et al. (2020). The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-alpha\/IL-33\/ST2L signaling promotes gastric cancer metastasis. Oncogene, 39(7), 1414\u20131428.","journal-title":"Oncogene"},{"key":"10265_CR36","doi-asserted-by":"crossref","unstructured":"Chen, B., et al., H. pylori-induced NF-\u03baB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling. Clin Transl Med, 2023. 13(11): p. e1481.","DOI":"10.1002\/ctm2.1481"},{"issue":"24","key":"10265_CR37","doi-asserted-by":"publisher","first-page":"14217","DOI":"10.1111\/jcmm.16038","volume":"24","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z., et al. (2020). A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos. Journal of Cellular and Molecular Medicine, 24(24), 14217\u201314230.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"44","key":"10265_CR38","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1038\/onc.2011.154","volume":"30","author":"J Jiang","year":"2011","unstructured":"Jiang, J., et al. (2011). IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer. Oncogene, 30(44), 4498\u20134508.","journal-title":"Oncogene"},{"issue":"1A","key":"10265_CR39","first-page":"17","volume":"25","author":"J Tokuyama","year":"2005","unstructured":"Tokuyama, J., et al. (2005). Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis. Anticancer Research, 25(1A), 17\u201322.","journal-title":"Anticancer Research"},{"key":"10265_CR40","doi-asserted-by":"crossref","unstructured":"Kaji, S., et al., Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence. Gastric Cancer., 2020.","DOI":"10.1007\/s10120-020-01065-5"},{"key":"10265_CR41","doi-asserted-by":"crossref","unstructured":"Wang, Y., et al., The clinical significance and functional role of miR-466 in gastric cancer peritoneal metastasis. Molecular Biotechnology., 2021.","DOI":"10.1007\/s12033-021-00382-z"},{"issue":"1","key":"10265_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12033-021-00382-z","volume":"64","author":"Y Wang","year":"2022","unstructured":"Wang, Y., et al. (2022). The clinical significance and functional role of miR-466 in gastric cancer peritoneal metastasis. Molecular Biotechnology, 64(1), 25\u201332.","journal-title":"Molecular Biotechnology"},{"issue":"1","key":"10265_CR43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.bbrc.2014.11.083","volume":"456","author":"Z Li","year":"2015","unstructured":"Li, Z., et al. (2015). Methylation-associated silencing of miR-495 inhibit the migration and invasion of human gastric cancer cells by directly targeting PRL-3. Biochemical & Biophysical Research Communications, 456(1), 344\u2013350.","journal-title":"Biochemical & Biophysical Research Communications"},{"key":"10265_CR44","doi-asserted-by":"crossref","unstructured":"Gao, N., et al., The role of TRPV1 ion channels in the suppression of gastric cancer development. Journal of Experimental and Clinical Cancer Research, 2020. 39(1) (no pagination).","DOI":"10.1186\/s13046-020-01707-7"},{"issue":"1","key":"10265_CR45","doi-asserted-by":"publisher","first-page":"12702","DOI":"10.1038\/s41598-019-49230-w","volume":"9","author":"A Takeuchi","year":"2019","unstructured":"Takeuchi, A., et al. (2019). Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer. Science and Reports, 9(1), 12702.","journal-title":"Science and Reports"},{"key":"10265_CR46","doi-asserted-by":"publisher","first-page":"215916","DOI":"10.1016\/j.canlet.2022.215916","volume":"549","author":"S Wang","year":"2022","unstructured":"Wang, S., et al. (2022). Delivery of LINC00589 via mesoporous silica nanoparticles inhibits peritoneal metastasis in gastric cancer. Cancer Letters, 549, 215916.","journal-title":"Cancer Letters"},{"issue":"1","key":"10265_CR47","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12943-023-01857-0","volume":"22","author":"JW Kwon","year":"2023","unstructured":"Kwon, J. W., et al. (2023). Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency. Molecular Cancer, 22(1), 156.","journal-title":"Molecular Cancer"},{"issue":"12","key":"10265_CR48","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1111\/jcmm.13258","volume":"21","author":"S Wu","year":"2017","unstructured":"Wu, S., et al. (2017). AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression. Journal of Cellular & Molecular Medicine, 21(12), 3481\u20133493.","journal-title":"Journal of Cellular & Molecular Medicine"},{"issue":"23","key":"10265_CR49","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1002\/cncr.27565","volume":"118","author":"TY Cheng","year":"2012","unstructured":"Cheng, T. Y., et al. (2012). Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor\/extracellular signal-regulated kinase\/integrin beta-1-binding protein 1 pathway. Cancer, 118(23), 5757\u20135767.","journal-title":"Cancer"},{"key":"10265_CR50","doi-asserted-by":"crossref","unstructured":"Wang, C., et al., Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K\/AKT\/mTOR pathway. Clinical and Translational Medicine, 2021. 11(8) (no pagination).","DOI":"10.1002\/ctm2.522"},{"issue":"6","key":"10265_CR51","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s10120-021-01201-9","volume":"24","author":"Y Ding","year":"2021","unstructured":"Ding, Y., et al. (2021). A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics. Gastric Cancer, 24(6), 1227\u20131241.","journal-title":"Gastric Cancer"},{"issue":"3","key":"10265_CR52","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1245\/s10434-017-6292-6","volume":"25","author":"Q Hu","year":"2018","unstructured":"Hu, Q., et al. (2018). Identification of ARL4C as a peritoneal dissemination-associated gene and its clinical significance in gastric cancer. Annals of Surgical Oncology, 25(3), 745\u2013753.","journal-title":"Annals of Surgical Oncology"},{"key":"10265_CR53","doi-asserted-by":"crossref","unstructured":"Xie, J.W., et al., m6A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling. Molecular Cancer, 2020. 19(1) (no pagination).","DOI":"10.1186\/s12943-020-01223-4"},{"issue":"2","key":"10265_CR54","doi-asserted-by":"publisher","first-page":"465","DOI":"10.7150\/ijbs.72218","volume":"19","author":"H Wu","year":"2023","unstructured":"Wu, H., et al. (2023). BGN\/FAP\/STAT3 positive feedback loop mediated mutual interaction between tumor cells and mesothelial cells contributes to peritoneal metastasis of gastric cancer. International Journal of Biological Sciences, 19(2), 465\u2013483.","journal-title":"International Journal of Biological Sciences"},{"issue":"6","key":"10265_CR55","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1349-7006.2005.00054.x","volume":"96","author":"K Yanagihara","year":"2005","unstructured":"Yanagihara, K., et al. (2005). Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Science, 96(6), 323\u2013332.","journal-title":"Cancer Science"},{"issue":"8","key":"10265_CR56","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.21873\/anticanres.15896","volume":"42","author":"H Kaku","year":"2022","unstructured":"Kaku, H., et al. (2022). Significance of intraperitoneal-free KRT20 and CEACAM6 mRNA expression for peritoneal recurrence of gastric cancer. Anticancer Research, 42(8), 4003\u20134010.","journal-title":"Anticancer Research"},{"issue":"38","key":"10265_CR57","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/s41388-021-01988-y","volume":"40","author":"S Du","year":"2021","unstructured":"Du, S., et al. (2021). Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C\/EBPbeta-mediated PDGFB autocrine and paracrine signaling. Oncogene, 40(38), 5764\u20135779.","journal-title":"Oncogene"},{"issue":"5","key":"10265_CR58","doi-asserted-by":"publisher","first-page":"e0154542","DOI":"10.1371\/journal.pone.0154542","volume":"11","author":"J Kitayama","year":"2016","unstructured":"Kitayama, J., et al. (2016). Intraperitoneal mesenchymal cells promote the development of peritoneal metastasis partly by supporting long migration of disseminated tumor cells. PLoS ONE [Electronic Resource], 11(5), e0154542.","journal-title":"PLoS ONE [Electronic Resource]"},{"key":"10265_CR59","doi-asserted-by":"publisher","first-page":"22371","DOI":"10.1038\/srep22371","volume":"6","author":"J Kurashige","year":"2016","unstructured":"Kurashige, J., et al. (2016). Integrated molecular profiling of human gastric cancer identifies DDR2 as a potential regulator of peritoneal dissemination. Scientific Reports, 6, 22371.","journal-title":"Scientific Reports"},{"key":"10265_CR60","doi-asserted-by":"publisher","first-page":"110636","DOI":"10.1016\/j.cellsig.2023.110636","volume":"106","author":"L Ren","year":"2023","unstructured":"Ren, L., et al. (2023). miR-199a-3p promotes gastric cancer progression by promoting its stemness potential via DDR2 mediation. Cellular Signalling, 106, 110636.","journal-title":"Cellular Signalling"},{"issue":"3","key":"10265_CR61","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3892\/or.2013.2961","volume":"31","author":"ZM Zhu","year":"2014","unstructured":"Zhu, Z. M., et al. (2014). DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway. Oncology Reports, 31(3), 1489\u20131497.","journal-title":"Oncology Reports"},{"issue":"1","key":"10265_CR62","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/IJPM.IJPM_777_19","volume":"64","author":"GM Zhu","year":"2021","unstructured":"Zhu, G. M., et al. (2021). MiR-216b inhibits gastric cancer proliferation and migration by targeting PARK7. Indian Journal of Pathology and Microbiology, 64(1), 52\u201357.","journal-title":"Indian Journal of Pathology and Microbiology"},{"issue":"4","key":"10265_CR63","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.7150\/ijbs.90598","volume":"20","author":"Y Jin","year":"2024","unstructured":"Jin, Y., et al. (2024). Blocking EGR1\/TGF-\u03b21 and CD44s\/STAT3 crosstalk inhibits peritoneal metastasis of gastric cancer. International Journal of Biological Sciences, 20(4), 1314\u20131331.","journal-title":"International Journal of Biological Sciences"},{"issue":"9","key":"10265_CR64","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s43018-021-00240-6","volume":"2","author":"Y Tanaka","year":"2021","unstructured":"Tanaka, Y., et al. (2021). Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities. Nat Cancer, 2(9), 962\u2013977.","journal-title":"Nat Cancer"},{"issue":"8","key":"10265_CR65","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41419-019-1776-x","volume":"10","author":"H Dong","year":"2019","unstructured":"Dong, H., et al. (2019). GLI1 activation by non-classical pathway integrin alphavbeta3\/ERK1\/2 maintains stem cell-like phenotype of multicellular aggregates in gastric cancer peritoneal metastasis. Cell Death & Disease, 10(8), 574.","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10265_CR66","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13046-022-02463-6","volume":"41","author":"Y Li","year":"2022","unstructured":"Li, Y., et al. (2022). GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma. Journal of Experimental & Clinical Cancer Research, 41(1), 257.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"12","key":"10265_CR67","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/cas.12301","volume":"104","author":"L Zhao","year":"2013","unstructured":"Zhao, L., et al. (2013). Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer. Cancer Science, 104(12), 1640\u20131646.","journal-title":"Cancer Science"},{"issue":"25","key":"10265_CR68","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.7150\/thno.36277","volume":"9","author":"C Wang","year":"2019","unstructured":"Wang, C., et al. (2019). A self-enforcing HOXA11\/Stat3 feedback loop promotes stemness properties and peritoneal metastasis in gastric cancer cells. Theranostics, 9(25), 7628\u20137647.","journal-title":"Theranostics"},{"issue":"7","key":"10265_CR69","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.7150\/ijbs.70524","volume":"18","author":"Y Fang","year":"2022","unstructured":"Fang, Y., et al. (2022). LAMC1-mediated preadipocytes differentiation promoted peritoneum pre-metastatic niche formation and gastric cancer metastasis. International Journal of Biological Sciences, 18(7), 3082\u20133101.","journal-title":"International Journal of Biological Sciences"},{"issue":"3","key":"10265_CR70","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10120-022-01284-y","volume":"25","author":"S Umeda","year":"2022","unstructured":"Umeda, S., et al. (2022). Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells. Gastric Cancer, 25(3), 558\u2013572.","journal-title":"Gastric Cancer"},{"issue":"19","key":"10265_CR71","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1038\/s41388-021-01656-1","volume":"40","author":"X Kang","year":"2021","unstructured":"Kang, X., et al. (2021). LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target. Oncogene, 40(19), 3422\u20133433.","journal-title":"Oncogene"},{"issue":"11","key":"10265_CR72","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41419-022-05436-x","volume":"13","author":"Q He","year":"2022","unstructured":"He, Q., et al. (2022). LINC00924-induced fatty acid metabolic reprogramming facilitates gastric cancer peritoneal metastasis via hnRNPC-regulated alternative splicing of Mnk2. Cell Death & Disease, 13(11), 987.","journal-title":"Cell Death & Disease"},{"key":"10265_CR73","doi-asserted-by":"crossref","unstructured":"Wang, Y., et al., High level of legumain was correlated with worse prognosis and peritoneal metastasis in gastric cancer patients. Frontiers in Oncology, 2020. 10 (no pagination).","DOI":"10.3389\/fonc.2020.00966"},{"issue":"50","key":"10265_CR74","doi-asserted-by":"publisher","first-page":"83223","DOI":"10.18632\/oncotarget.12917","volume":"7","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y., et al. (2016). MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain. Oncotarget, 7(50), 83223\u201383230.","journal-title":"Oncotarget"},{"issue":"1","key":"10265_CR75","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12885-022-09541-0","volume":"22","author":"Y Tan","year":"2022","unstructured":"Tan, Y., et al. (2022). LMOD1, an oncogene associated with Lauren classification, regulates the metastasis of gastric cancer cells through the FAK-AKT\/mTOR pathway. BMC Cancer, 22(1), 474.","journal-title":"BMC Cancer"},{"issue":"3","key":"10265_CR76","first-page":"1026","volume":"10","author":"D Zang","year":"2020","unstructured":"Zang, D., et al. (2020). LPPR4 promotes peritoneal metastasis via Sp1\/integrin alpha\/FAK signaling in gastric cancer. American Journal of Cancer Research, 10(3), 1026\u20131044.","journal-title":"American Journal of Cancer Research"},{"issue":"15","key":"10265_CR77","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.7150\/thno.75431","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang, Y., et al. (2022). MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target. Theranostics, 12(15), 6509\u20136526.","journal-title":"Theranostics"},{"issue":"100","key":"10265_CR78","first-page":"1476","volume":"13","author":"T Du","year":"2014","unstructured":"Du, T., et al. (2014). Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK\/Paxillin pathway. Molecular Cancer, 13(100), 1476\u20134598.","journal-title":"Molecular Cancer"},{"key":"10265_CR79","doi-asserted-by":"crossref","unstructured":"Nagamura, Y., et al., PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification. Oncogenesis, 2021. 10(3) (no pagination).","DOI":"10.1038\/s41389-021-00314-1"},{"issue":"19","key":"10265_CR80","doi-asserted-by":"publisher","first-page":"16960","DOI":"10.1074\/jbc.M200673200","volume":"277","author":"S Ihara","year":"2002","unstructured":"Ihara, S., et al. (2002). Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1\u20136 GlcNAc branching. Journal of Biological Chemistry, 277(19), 16960\u201316967.","journal-title":"Journal of Biological Chemistry"},{"key":"10265_CR81","doi-asserted-by":"publisher","first-page":"110230","DOI":"10.1016\/j.cellsig.2021.110230","volume":"91","author":"M Zhu","year":"2022","unstructured":"Zhu, M., et al. (2022). Integration of exosomal miR-106a and mesothelial cells facilitates gastric cancer peritoneal dissemination. Cellular Signalling, 91, 110230.","journal-title":"Cellular Signalling"},{"issue":"6","key":"10265_CR82","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.clinre.2016.05.006","volume":"40","author":"R Xin","year":"2016","unstructured":"Xin, R., et al. (2016). MicroRNA-214 promotes peritoneal metastasis through regulating PTEN negatively in gastric cancer. Clinics & Research in Hepatology & Gastroenterology, 40(6), 748\u2013754.","journal-title":"Clinics & Research in Hepatology & Gastroenterology"},{"key":"10265_CR83","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.canlet.2017.08.017","volume":"408","author":"DH Ma","year":"2017","unstructured":"Ma, D. H., et al. (2017). miR-93-5p\/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway. Cancer Letters, 408, 23\u201332.","journal-title":"Cancer Letters"},{"issue":"2","key":"10265_CR84","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1016\/j.jss.2010.09.041","volume":"164","author":"EJ Cabourne","year":"2010","unstructured":"Cabourne, E. J., et al. (2010). Investigation of tumor-peritoneal interactions in the pathogenesis of peritoneal metastases using a novel ex vivo peritoneal model1. Journal of Surgical Research, 164(2), e265\u2013e272.","journal-title":"Journal of Surgical Research"},{"issue":"12","key":"10265_CR85","doi-asserted-by":"publisher","first-page":"09","DOI":"10.3390\/ijms19123961","volume":"19","author":"T Oku","year":"2018","unstructured":"Oku, T., et al. (2018). Stimulation of peritoneal mesothelial cells to secrete matrix metalloproteinase-9 (MMP-9) by TNF-alpha: A role in the invasion of gastric carcinoma cells. International Journal of Molecular Sciences, 19(12), 09.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10265_CR86","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/PL00011698","volume":"3","author":"Y Yonemura","year":"2000","unstructured":"Yonemura, Y., et al. (2000). Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer. Gastric Cancer, 3(2), 63\u201370.","journal-title":"Gastric Cancer"},{"issue":"10","key":"10265_CR87","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.7150\/jca.39645","volume":"11","author":"S Zhang","year":"2020","unstructured":"Zhang, S., et al. (2020). Identification of key gene and pathways for the prediction of peritoneal metastasis of gastric cancer by co-expression analysis. Journal of Cancer, 11(10), 3041\u20133051.","journal-title":"Journal of Cancer"},{"issue":"17","key":"10265_CR88","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.7150\/thno.46001","volume":"10","author":"G Ye","year":"2020","unstructured":"Ye, G., et al. (2020). Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis. Theranostics, 10(17), 7545\u20137560.","journal-title":"Theranostics"},{"issue":"24","key":"10265_CR89","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41388-023-02707-5","volume":"42","author":"K Liu","year":"2023","unstructured":"Liu, K., et al. (2023). Peritoneal high-fat environment promotes peritoneal metastasis of gastric cancer cells through activation of NSUN2-mediated ORAI2 m5C modification. Oncogene, 42(24), 1980\u20131993.","journal-title":"Oncogene"},{"issue":"2","key":"10265_CR90","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1349-7006.2011.02155.x","volume":"103","author":"N Nishioka","year":"2012","unstructured":"Nishioka, N., et al. (2012). Plasminogen activator inhibitor 1 RNAi suppresses gastric cancer metastasis in vivo. Cancer Science, 103(2), 228\u2013232.","journal-title":"Cancer Science"},{"issue":"5\u20136","key":"10265_CR91","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1159\/000129635","volume":"21","author":"D Zieker","year":"2008","unstructured":"Zieker, D., et al. (2008). PGK1 a potential marker for peritoneal dissemination in gastric cancer. Cellular Physiology & Biochemistry, 21(5\u20136), 429\u2013436.","journal-title":"Cellular Physiology & Biochemistry"},{"issue":"11","key":"10265_CR92","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.7150\/jca.14844","volume":"7","author":"X Tan","year":"2016","unstructured":"Tan, X., et al. (2016). A point mutation in DNA polymerase beta (POLB) gene is associated with increased progesterone receptor (PR) expression and intraperitoneal metastasis in gastric cancer. Journal of Cancer, 7(11), 1472\u20131480.","journal-title":"Journal of Cancer"},{"key":"10265_CR93","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clinbiochem.2018.04.003","volume":"56","author":"J Jin","year":"2018","unstructured":"Jin, J., et al. (2018). Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers. Clinical Biochemistry, 56, 55\u201361.","journal-title":"Clinical Biochemistry"},{"issue":"4","key":"10265_CR94","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3892\/or.2016.5030","volume":"36","author":"J Xiong","year":"2016","unstructured":"Xiong, J., et al. (2016). PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K\/Akt signaling pathway by regulating PTEN. Oncology Reports, 36(4), 1819\u20131828.","journal-title":"Oncology Reports"},{"issue":"6","key":"10265_CR95","first-page":"9069","volume":"15","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., et al. (2018). PRL-3 promotes gastric cancer peritoneal metastasis via the PI3K\/AKT signaling pathway in vitro and in vivo. Oncology Letters, 15(6), 9069\u20139074.","journal-title":"Oncology Letters"},{"issue":"1","key":"10265_CR96","doi-asserted-by":"publisher","first-page":"13995","DOI":"10.1038\/s41598-019-50171-7","volume":"9","author":"C Chen","year":"2019","unstructured":"Chen, C., et al. (2019). Molecular profiles and metastasis markers in Chinese patients with gastric carcinoma. Scientific Reports, 9(1), 13995.","journal-title":"Scientific Reports"},{"key":"10265_CR97","doi-asserted-by":"publisher","first-page":"153303382211460","DOI":"10.1177\/15330338221146024","volume":"22","author":"S Nakamura","year":"2023","unstructured":"Nakamura, S., et al. (2023). RhoA G17E\/Vav1 signaling induces cancer invasion via matrix metalloproteinase-9 in gastric cancer. Technology in Cancer Research & Treatment, 22, 15330338221146024.","journal-title":"Technology in Cancer Research & Treatment"},{"issue":"7","key":"10265_CR98","doi-asserted-by":"publisher","first-page":"8055","DOI":"10.18632\/oncotarget.6977","volume":"7","author":"B Lim","year":"2016","unstructured":"Lim, B., et al. (2016). Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites. Oncotarget, 7(7), 8055\u20138066.","journal-title":"Oncotarget"},{"key":"10265_CR99","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12935-020-01275-y","volume":"20","author":"M Shao","year":"2020","unstructured":"Shao, M., et al. (2020). SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis. Cancer Cell International, 20, 188.","journal-title":"Cancer Cell International"},{"key":"10265_CR100","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.2147\/CMAR.S177373","volume":"10","author":"X Zhang","year":"2018","unstructured":"Zhang, X., et al. (2018). SALL4 activates TGF-beta\/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis. Cancer management and research, 10, 4459\u20134470.","journal-title":"Cancer management and research"},{"key":"10265_CR101","doi-asserted-by":"publisher","first-page":"5055684","DOI":"10.1155\/2022\/5055684","volume":"2022","author":"G Huang","year":"2022","unstructured":"Huang, G., et al. (2022). The lncRNA SEMA3B-AS1\/HMGB1\/FBXW7 axis mediates the peritoneal metastasis of gastric cancer by regulating BGN protein ubiquitination. Oxidative Medicine and Cellular Longevity, 2022, 5055684.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"2","key":"10265_CR102","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/jso.23472","volume":"109","author":"S Tamura","year":"2014","unstructured":"Tamura, S., et al. (2014). Prognostic information derived from RT-PCR analysis of peritoneal fluid in gastric cancer patients: Results from a prospective multicenter clinical trial. Journal of Surgical Oncology, 109(2), 75\u201380.","journal-title":"Journal of Surgical Oncology"},{"issue":"3","key":"10265_CR103","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/SLA.0000000000002096","volume":"267","author":"M Kanda","year":"2018","unstructured":"Kanda, M., et al. (2018). Significance of SYT8 for the detection, prediction, and treatment of peritoneal metastasis from gastric cancer. Annals of Surgery, 267(3), 495\u2013503.","journal-title":"Annals of Surgery"},{"issue":"10","key":"10265_CR104","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/bjs.10876","volume":"105","author":"M Kanda","year":"2018","unstructured":"Kanda, M., et al. (2018). Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer. British Journal of Surgery, 105(10), 1349\u20131358.","journal-title":"British Journal of Surgery"},{"issue":"12","key":"10265_CR105","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1007\/s12094-023-03194-6","volume":"25","author":"C Ji","year":"2023","unstructured":"Ji, C., et al. (2023). Single-cell RNA sequencing reveals the lineage of malignant epithelial cells and upregulation of TAGLN2 promotes peritoneal metastasis in gastric cancer. Clinical and Translational Oncology, 25(12), 3405\u20133419.","journal-title":"Clinical and Translational Oncology"},{"issue":"13","key":"10265_CR106","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1038\/onc.2016.352","volume":"36","author":"Q Zhou","year":"2017","unstructured":"Zhou, Q., et al. (2017). Transducin (beta)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1\/2 pathway. Oncogene, 36(13), 1873\u20131886.","journal-title":"Oncogene"},{"key":"10265_CR107","doi-asserted-by":"crossref","unstructured":"Hu, X.Y., et al., Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer. Journal of Clinical Laboratory Analysis, 2021. 35(9) (no pagination).","DOI":"10.1002\/jcla.23936"},{"issue":"2","key":"10265_CR108","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10585-021-10133-8","volume":"39","author":"V Sangwan","year":"2022","unstructured":"Sangwan, V., et al. (2022). Inhibition of LPS-mediated TLR4 activation abrogates gastric adenocarcinoma-associated peritoneal metastasis. Clinical & Experimental Metastasis, 39(2), 323\u2013333.","journal-title":"Clinical & Experimental Metastasis"},{"key":"10265_CR109","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.omtn.2019.10.020","volume":"19","author":"Y Cao","year":"2020","unstructured":"Cao, Y., et al. (2020). Long noncoding RNA UCA1 regulates PRL-3 expression by sponging microRNA-495 to promote the progression of gastric cancer. Molecular Therapy - Nucleic Acids, 19, 853\u2013864.","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"1","key":"10265_CR110","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/gutjnl-2019-319748","volume":"70","author":"JA Ajani","year":"2021","unstructured":"Ajani, J. A., et al. (2021). YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition. Gut, 70(1), 55\u201366.","journal-title":"Gut"},{"issue":"4","key":"10265_CR111","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1245\/s10434-009-0854-1","volume":"17","author":"A Takeno","year":"2010","unstructured":"Takeno, A., et al. (2010). Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer. Annals of Surgical Oncology, 17(4), 1033\u20131042.","journal-title":"Annals of Surgical Oncology"},{"issue":"10","key":"10265_CR112","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/sj.bjc.6600580","volume":"87","author":"C Sakakura","year":"2002","unstructured":"Sakakura, C., et al. (2002). Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. British Journal of Cancer, 87(10), 1153\u20131161.","journal-title":"British Journal of Cancer"},{"issue":"6 SUPPL.","key":"10265_CR113","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/1097-0142(19950315)75:6+<1539::AID-CNCR2820751526>3.0.CO;2-L","volume":"75","author":"T Asao","year":"1995","unstructured":"Asao, T., et al. (1995). Fucosyltransferases of the peritoneum contributed to the adhesion of cancer cells to the mesothelium. Cancer, 75(6 SUPPL.), 1539\u20131544.","journal-title":"Cancer"},{"issue":"2","key":"10265_CR114","first-page":"336","volume":"5","author":"K Fukuda","year":"2012","unstructured":"Fukuda, K., et al. (2012). Role of integrin alpha1 subunits in gastric cancer patients with peritoneal dissemination. Molecular Medicine Reports, 5(2), 336\u2013340.","journal-title":"Molecular Medicine Reports"},{"issue":"9","key":"10265_CR115","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/bjc.1996.556","volume":"74","author":"S Nishimura","year":"1996","unstructured":"Nishimura, S., et al. (1996). Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. British Journal of Cancer, 74(9), 1406\u20131412.","journal-title":"British Journal of Cancer"},{"issue":"12","key":"10265_CR116","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1349-7006.1996.tb03138.x","volume":"87","author":"S Nishimura","year":"1996","unstructured":"Nishimura, S., et al. (1996). CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells. Japanese Journal of Cancer Research, 87(12), 1235\u20131244.","journal-title":"Japanese Journal of Cancer Research"},{"issue":"7","key":"10265_CR117","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1349-7006.2000.tb01004.x","volume":"91","author":"H Nishimori","year":"2000","unstructured":"Nishimori, H., et al. (2000). A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: Different mechanisms in peritoneal dissemination and hematogenous metastasis. Japanese Journal of Cancer Research, 91(7), 715\u2013722.","journal-title":"Japanese Journal of Cancer Research"},{"issue":"8","key":"10265_CR118","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/j.1349-7006.2009.01211.x","volume":"100","author":"T Nishii","year":"2009","unstructured":"Nishii, T., et al. (2009). Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma. Cancer Science, 100(8), 1397\u20131402.","journal-title":"Cancer Science"},{"key":"10265_CR119","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.canlet.2021.11.008","volume":"526","author":"S Miyamoto","year":"2022","unstructured":"Miyamoto, S., et al. (2022). Integrin \u03b15 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma. Cancer Letters, 526, 335\u2013345.","journal-title":"Cancer Letters"},{"issue":"4","key":"10265_CR120","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.21873\/anticanres.16295","volume":"43","author":"YM Yang","year":"2023","unstructured":"Yang, Y. M., et al. (2023). ALCAM, activated leukocyte cell adhesion molecule, in clinical gastric cancer and patient\u2019s response to chemotherapies. Anticancer Research, 43(4), 1463\u20131475.","journal-title":"Anticancer Research"},{"key":"10265_CR121","doi-asserted-by":"crossref","unstructured":"Na, D., et al., Destruction of gastric cancer cells to mesothelial cells by apoptosis in the early peritoneal metastasis. Journal of Huazhong University of Science and Technology. Medical Sciences, 2009. 29(2): p. 163\u20138.","DOI":"10.1007\/s11596-009-0205-2"},{"key":"10265_CR122","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.lfs.2018.10.017","volume":"213","author":"R Kimura","year":"2018","unstructured":"Kimura, R., et al. (2018). Expression of cell adhesion molecule 1 in gastric neck and base glandular cells: Possible involvement in peritoneal dissemination of signet ring cells. Life Sciences, 213, 206\u2013213.","journal-title":"Life Sciences"},{"issue":"6","key":"10265_CR123","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1593\/tlo.13499","volume":"6","author":"A Mencarelli","year":"2013","unstructured":"Mencarelli, A., et al. (2013). CCR5 antagonism by maraviroc reduces the potential for gastric cancer cell dissemination. Translational Oncology, 6(6), 784\u2013793.","journal-title":"Translational Oncology"},{"issue":"6","key":"10265_CR124","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.21873\/anticanres.16416","volume":"43","author":"AM Sihombing","year":"2023","unstructured":"Sihombing, A. M., et al. (2023). CD44-positive cancer stem-like cells as a potential source of peritoneal metastasis after surgery. Anticancer Research, 43(6), 2491\u20132500.","journal-title":"Anticancer Research"},{"issue":"5","key":"10265_CR125","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/cas.13218","volume":"108","author":"K Nakashima","year":"2017","unstructured":"Nakashima, K., et al. (2017). Novel small molecule inhibiting CDCP1-PKCdelta pathway reduces tumor metastasis and proliferation. Cancer Science, 108(5), 1049\u20131057.","journal-title":"Cancer Science"},{"issue":"1","key":"10265_CR126","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12885-023-10544-8","volume":"23","author":"C Dong","year":"2023","unstructured":"Dong, C., et al. (2023). Identification and validation of crucial lnc-TRIM28-14 and hub genes promoting gastric cancer peritoneal metastasis. BMC Cancer, 23(1), 76.","journal-title":"BMC Cancer"},{"key":"10265_CR127","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3389\/fonc.2019.01243","volume":"9","author":"B Bao","year":"2019","unstructured":"Bao, B., et al. (2019). Identification of subtype-specific three-gene signature for prognostic prediction in diffuse type gastric cancer. Frontiers in Oncology, 9, 1243.","journal-title":"Frontiers in Oncology"},{"key":"10265_CR128","doi-asserted-by":"crossref","unstructured":"Kim, S.R., et al., Clinical significance of CLDN18.2 expression in metastatic diffuse-type gastric cancer. Journal of Gastric Cancer, 2020. 20(4): p. 408\u2013420.","DOI":"10.5230\/jgc.2020.20.e33"},{"issue":"9","key":"10265_CR129","doi-asserted-by":"publisher","first-page":"e74527","DOI":"10.1371\/journal.pone.0074527","volume":"8","author":"B Tang","year":"2013","unstructured":"Tang, B., et al. (2013). Aberrant expression of Cx43 is associated with the peritoneal metastasis of gastric cancer and Cx43-mediated gap junction enhances gastric cancer cell diapedesis from peritoneal mesothelium. PLoS ONE [Electronic Resource], 8(9), e74527.","journal-title":"PLoS ONE [Electronic Resource]"},{"issue":"4","key":"10265_CR130","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11523-012-0239-4","volume":"8","author":"M Imano","year":"2013","unstructured":"Imano, M., et al. (2013). High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer. Targeted Oncology, 8(4), 231\u2013235.","journal-title":"Targeted Oncology"},{"issue":"35","key":"10265_CR131","doi-asserted-by":"publisher","first-page":"56855","DOI":"10.18632\/oncotarget.10869","volume":"7","author":"T Arita","year":"2016","unstructured":"Arita, T., et al. (2016). Tumor exosome-mediated promotion of adhesion to mesothelial cells in gastric cancer cells. Oncotarget, 7(35), 56855\u201356863.","journal-title":"Oncotarget"},{"key":"10265_CR132","doi-asserted-by":"crossref","unstructured":"Hachisu, K., et al., Galectin-4 is involved in the structural changes of glycosphingolipid glycans in poorly differentiated gastric cancer cells with high metastatic potential. Int J Mol Sci, 2023. 24(15).","DOI":"10.3390\/ijms241512305"},{"issue":"12","key":"10265_CR133","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41416-019-0646-8","volume":"121","author":"T Ichikawa","year":"2019","unstructured":"Ichikawa, T., et al. (2019). Clinical significance and biological role of L1 cell adhesion molecule in gastric cancer. British Journal of Cancer, 121(12), 1058\u20131068.","journal-title":"British Journal of Cancer"},{"issue":"6","key":"10265_CR134","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ijc.2910640611","volume":"64","author":"B Mayer","year":"1995","unstructured":"Mayer, B., et al. (1995). Expression of leukocyte cell adhesion molecules on gastric carcinomas: Possible involvement of LFA-3 expression in the development of distant metastases. International Journal of Cancer, 64(6), 415\u2013423.","journal-title":"International Journal of Cancer"},{"issue":"2","key":"10265_CR135","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.yexcr.2018.04.028","volume":"368","author":"X Wang","year":"2018","unstructured":"Wang, X., et al. (2018). Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1. Experimental Cell Research, 368(2), 184\u2013193.","journal-title":"Experimental Cell Research"},{"key":"10265_CR136","doi-asserted-by":"crossref","unstructured":"Ozaki, H., et al., Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model. Clinical and Experimental Metastasis, 2012: p. 1\u201310.","DOI":"10.1007\/s10585-011-9445-1"},{"issue":"11","key":"10265_CR137","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1007\/s00464-010-1067-1","volume":"24","author":"G Yu","year":"2010","unstructured":"Yu, G., et al. (2010). Systemic and peritoneal inflammatory response after laparoscopic-assisted gastrectomy and the effect of inflammatory cytokines on adhesion of gastric cancer cells to peritoneal mesothelial cells. Surgical Endoscopy, 24(11), 2860\u20132870.","journal-title":"Surgical Endoscopy"},{"key":"10265_CR138","doi-asserted-by":"crossref","unstructured":"Ranieri, D., et al., High adhesion of tumor cells to mesothelial monolayers derived from peritoneal wash of disseminated gastrointestinal cancers. PLoS ONE, 2013. 8 (2) (no pagination)(e57659).","DOI":"10.1371\/journal.pone.0057659"},{"issue":"8","key":"10265_CR139","doi-asserted-by":"publisher","first-page":"8301","DOI":"10.1007\/s13277-014-2093-8","volume":"35","author":"D Na","year":"2014","unstructured":"Na, D., et al. (2014). Induction of apoptosis in human peritoneal mesothelial cells by gastric cancer cell supernatant promotes peritoneal carcinomatosis. Tumour Biology, 35(8), 8301\u20138307.","journal-title":"Tumour Biology"},{"issue":"47","key":"10265_CR140","doi-asserted-by":"publisher","first-page":"34594","DOI":"10.1074\/jbc.M706600200","volume":"282","author":"MT Lin","year":"2007","unstructured":"Lin, M. T., et al. (2007). Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1. Journal of Biological Chemistry, 282(47), 34594\u201334604.","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10265_CR141","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s10120-014-0400-0","volume":"18","author":"CN Chen","year":"2015","unstructured":"Chen, C. N., et al. (2015). Connective tissue growth factor inhibits gastric cancer peritoneal metastasis by blocking integrin alpha3beta1-dependent adhesion. Gastric Cancer, 18(3), 504\u2013515.","journal-title":"Gastric Cancer"},{"issue":"2\u20133","key":"10265_CR142","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S1359-6349(09)71356-4","volume":"7","author":"K Mino","year":"2009","unstructured":"Mino, K., et al. (2009). A novel NF-kB inhibitor DHMEQ could suppress peritoneal dissemination of gastric cancer by anti-tumor\/-adhesive effects in mice. European Journal of Cancer, Supplement, 7(2\u20133), 399\u2013400.","journal-title":"European Journal of Cancer, Supplement"},{"key":"10265_CR143","doi-asserted-by":"crossref","unstructured":"Mencarelli, A., et al., Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis. Gastroenterology, 2011. 1): p. S1061.","DOI":"10.1016\/S0016-5085(11)64413-2"},{"issue":"2","key":"10265_CR144","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jso.22021","volume":"105","author":"JH Moon","year":"2012","unstructured":"Moon, J. H., et al. (2012). REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma. Journal of Surgical Oncology, 105(2), 189\u2013194.","journal-title":"Journal of Surgical Oncology"},{"issue":"19","key":"10265_CR145","doi-asserted-by":"publisher","first-page":"27874","DOI":"10.18632\/oncotarget.8442","volume":"7","author":"H Wang","year":"2016","unstructured":"Wang, H., et al. (2016). REG4 promotes peritoneal metastasis of gastric cancer through GPR37. Oncotarget, 7(19), 27874\u201327888.","journal-title":"Oncotarget"},{"issue":"2b","key":"10265_CR146","first-page":"1169","volume":"28","author":"K Miyagawa","year":"2008","unstructured":"Miyagawa, K., et al. (2008). Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastasis. Anticancer Research, 28(2b), 1169\u20131179.","journal-title":"Anticancer Research"},{"issue":"4","key":"10265_CR147","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/cam4.2041","volume":"8","author":"S Yin","year":"2019","unstructured":"Yin, S., et al. (2019). SPHK1-induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination. Cancer Medicine, 8(4), 1731\u20131743.","journal-title":"Cancer Medicine"},{"issue":"5","key":"10265_CR148","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/(SICI)1097-0215(19970304)70:5<612::AID-IJC20>3.0.CO;2-D","volume":"70","author":"T Nakashio","year":"1997","unstructured":"Nakashio, T., et al. (1997). Adhesion molecules and TGF-beta1 are involved in the peritoneal dissemination of NUGC-4 human gastric cancer cells. International Journal of Cancer, 70(5), 612\u2013618.","journal-title":"International Journal of Cancer"},{"issue":"9","key":"10265_CR149","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1158\/1078-0432.CCR-07-1634","volume":"14","author":"H Kawajiri","year":"2008","unstructured":"Kawajiri, H., et al. (2008). A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Clinical Cancer Research, 14(9), 2850\u20132860.","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10265_CR150","first-page":"355","volume":"16","author":"T Koyama","year":"2000","unstructured":"Koyama, T., et al. (2000). TGF-beta1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells. International journal of oncology, 16(2), 355\u2013362.","journal-title":"International journal of oncology"},{"issue":"1","key":"10265_CR151","doi-asserted-by":"publisher","first-page":"e86516","DOI":"10.1371\/journal.pone.0086516","volume":"9","author":"J Kitayama","year":"2014","unstructured":"Kitayama, J., et al. (2014). CD90+ mesothelial-like cells in peritoneal fluid promote peritoneal metastasis by forming a tumor permissive microenvironment. PLoS ONE [Electronic Resource], 9(1), e86516.","journal-title":"PLoS ONE [Electronic Resource]"},{"key":"10265_CR152","doi-asserted-by":"crossref","unstructured":"Lv, Z.D., et al., Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis. Journal of Experimental and Clinical Cancer Research, 2010. 29 (1) (no pagination)(139).","DOI":"10.1186\/1756-9966-29-139"},{"issue":"2","key":"10265_CR153","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3892\/or.2014.3636","volume":"33","author":"T Shinbo","year":"2015","unstructured":"Shinbo, T., et al. (2015). Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-beta signaling pathway. Oncology Reports, 33(2), 553\u2013558.","journal-title":"Oncology Reports"},{"issue":"1","key":"10265_CR154","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10120-017-0726-5","volume":"21","author":"H Saito","year":"2018","unstructured":"Saito, H., et al. (2018). Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: Inhibition of growth and fibrosis by tranilast. Gastric Cancer, 21(1), 55\u201367.","journal-title":"Gastric Cancer"},{"key":"10265_CR155","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1477-7819-10-270","volume":"10","author":"Y Ding","year":"2012","unstructured":"Ding, Y., et al. (2012). u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer. World Journal of Surgical Oncology, 10, 270.","journal-title":"World Journal of Surgical Oncology"},{"issue":"6","key":"10265_CR156","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.3892\/ol.2016.4498","volume":"11","author":"Y Ding","year":"2016","unstructured":"Ding, Y., et al. (2016). Effect of urokinase-type plasminogen activator system in gastric cancer with peritoneal metastasis. Oncology Letters, 11(6), 4208\u20134216.","journal-title":"Oncology Letters"},{"issue":"3","key":"10265_CR157","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1600-0463.2010.02707.x","volume":"119","author":"F Chang-Qing","year":"2011","unstructured":"Chang-Qing, F., et al. (2011). Immune clearance gastric carcinoma cells in ascites by activating caspase-9-induced apoptosis. APMIS, 119(3), 173\u2013179.","journal-title":"APMIS"},{"issue":"23","key":"10265_CR158","doi-asserted-by":"publisher","first-page":"24009","DOI":"10.18632\/aging.104082","volume":"12","author":"W Kong","year":"2020","unstructured":"Kong, W., et al. (2020). Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer. Aging, 12(23), 24009\u201324022.","journal-title":"Aging"},{"key":"10265_CR159","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3389\/fonc.2019.01267","volume":"9","author":"O Kersy","year":"2019","unstructured":"Kersy, O., et al. (2019). Omental tissue-mediated tumorigenesis of gastric cancer peritoneal metastases. Frontiers in Oncology, 9, 1267.","journal-title":"Frontiers in Oncology"},{"key":"10265_CR160","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2019.04.034","volume":"457","author":"Y Hu","year":"2019","unstructured":"Hu, Y., et al. (2019). Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer. Cancer Letters, 457, 142\u2013150.","journal-title":"Cancer Letters"},{"key":"10265_CR161","doi-asserted-by":"crossref","unstructured":"Li, B., et al., Exosomal miR-21\u20135p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition. Cell Death and Disease, 2018. 9 (9) (no pagination)(854).","DOI":"10.1038\/s41419-018-0928-8"},{"issue":"14","key":"10265_CR162","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/1873-3468.12722","volume":"591","author":"G Deng","year":"2017","unstructured":"Deng, G., et al. (2017). Gastric cancer-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier. FEBS Letters, 591(14), 2167\u20132179.","journal-title":"FEBS Letters"},{"key":"10265_CR163","doi-asserted-by":"crossref","unstructured":"Ito, A., et al., Extracellular vesicles shed from gastric cancer mediate protumor macrophage differentiation. BMC Cancer, 2021. 21(1) (no pagination).","DOI":"10.1186\/s12885-021-07816-6"},{"issue":"3","key":"10265_CR164","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3892\/etm.2012.600","volume":"4","author":"M Hiraki","year":"2012","unstructured":"Hiraki, M., et al. (2012). Knockdown of hypoxia-inducible factor-1alpha accelerates peritoneal dissemination via the upregulation of MMP-1 expression in gastric cancer cell lines. Experimental & Therapeutic Medicine, 4(3), 355\u2013362.","journal-title":"Experimental & Therapeutic Medicine"},{"issue":"1","key":"10265_CR165","doi-asserted-by":"publisher","first-page":"11127","DOI":"10.1038\/s41598-017-11769-x","volume":"7","author":"K Baba","year":"2017","unstructured":"Baba, K., et al. (2017). Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines. Scientific Reports, 7(1), 11127.","journal-title":"Scientific Reports"},{"issue":"5","key":"10265_CR166","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/sj.bjc.6605543","volume":"102","author":"Y Kato","year":"2010","unstructured":"Kato, Y., et al. (2010). Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12\/Hypo, derived from a scirrhous gastric carcinoma. British Journal of Cancer, 102(5), 898\u2013907.","journal-title":"British Journal of Cancer"},{"issue":"12","key":"10265_CR167","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1002\/stem.1816","volume":"32","author":"ZF Miao","year":"2014","unstructured":"Miao, Z. F., et al. (2014). Peritoneal milky spots serve as a hypoxic niche and favor gastric cancer stem\/progenitor cell peritoneal dissemination through hypoxia-inducible factor 1alpha. Stem Cells, 32(12), 3062\u20133074.","journal-title":"Stem Cells"},{"issue":"5","key":"10265_CR168","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3892\/ijo.2013.2068","volume":"43","author":"S Miyake","year":"2013","unstructured":"Miyake, S., et al. (2013). HIF-1alpha is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer. International Journal of Oncology, 43(5), 1431\u20131440.","journal-title":"International Journal of Oncology"},{"key":"10265_CR169","doi-asserted-by":"publisher","first-page":"102312","DOI":"10.1016\/j.redox.2022.102312","volume":"52","author":"Z Lin","year":"2022","unstructured":"Lin, Z., et al. (2022). Hypoxia-induced HIF-1\u03b1\/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer. Redox Biology, 52, 102312.","journal-title":"Redox Biology"},{"key":"10265_CR170","doi-asserted-by":"crossref","unstructured":"Wang, X., et al., Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin alpha5-fibronectin pathway. Journal of Experimental and Clinical Cancer Research, 2020. 39(1) (no pagination).","DOI":"10.1186\/s13046-020-01703-x"},{"issue":"5","key":"10265_CR171","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/ijc.31410","volume":"143","author":"Y Kiyozumi","year":"2018","unstructured":"Kiyozumi, Y., et al. (2018). PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer. International Journal of Cancer, 143(5), 1202\u20131211.","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10265_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-014-0267-1","volume":"12","author":"L Cao","year":"2014","unstructured":"Cao, L., et al. (2014). The role of the CCL22-CCR4 axis in the metastasis of gastric cancer cells into omental milky spots. Journal of Translational Medicine, 12(1), 1\u201310.","journal-title":"Journal of Translational Medicine"},{"issue":"3","key":"10265_CR173","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.bbrc.2013.08.073","volume":"439","author":"XY Liu","year":"2013","unstructured":"Liu, X. Y., et al. (2013). Milky spot macrophages remodeled by gastric cancer cells promote peritoneal mesothelial cell injury. Biochemical & Biophysical Research Communications, 439(3), 378\u2013383.","journal-title":"Biochemical & Biophysical Research Communications"},{"issue":"1","key":"10265_CR174","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1023\/B:CLIN.0000017181.01474.35","volume":"21","author":"Y Mochizuki","year":"2004","unstructured":"Mochizuki, Y., et al. (2004). TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clinical & Experimental Metastasis, 21(1), 39\u201347.","journal-title":"Clinical & Experimental Metastasis"},{"issue":"3","key":"10265_CR175","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41416-020-0898-3","volume":"123","author":"M Natsume","year":"2020","unstructured":"Natsume, M., et al. (2020). Omental adipocytes promote peritoneal metastasis of gastric cancer through the CXCL2-VEGFA axis. British Journal of Cancer, 123(3), 459\u2013470.","journal-title":"British Journal of Cancer"},{"key":"10265_CR176","doi-asserted-by":"crossref","unstructured":"Li, S., et al., Obesity promotes gastric cancer metastasis via diacylglycerol acyltransferase 2-dependent lipid droplets accumulation and redox homeostasis. Redox Biology, 2020. 36 (no pagination).","DOI":"10.1016\/j.redox.2020.101596"},{"key":"10265_CR177","doi-asserted-by":"crossref","unstructured":"Yasuda, T., et al., Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination. Cell Reports, 2021. 34(8) (no pagination).","DOI":"10.1016\/j.celrep.2021.108779"},{"issue":"16","key":"10265_CR178","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1158\/0008-5472.CAN-19-3803","volume":"80","author":"T Uchihara","year":"2020","unstructured":"Uchihara, T., et al. (2020). Extracellular vesicles from cancer-associated fibroblasts containing annexin A6 induces FAK-YAP activation by stabilizing b1 integrin, enhancing drug resistance. Cancer Research, 80(16), 3222\u20133235.","journal-title":"Cancer Research"},{"issue":"2","key":"10265_CR179","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/jpi.12295","volume":"60","author":"SM Wu","year":"2016","unstructured":"Wu, S. M., et al. (2016). Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain-mediated C\/EBPbeta and NFkappaB cleavage. Journal of Pineal Research, 60(2), 142\u2013154.","journal-title":"Journal of Pineal Research"},{"issue":"8 Suppl","key":"10265_CR180","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1668::AID-CNCR37>3.0.CO;2-W","volume":"77","author":"M Yashiro","year":"1996","unstructured":"Yashiro, M., et al. (1996). Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as \u201csoil\u201d for peritoneal dissemination. Cancer, 77(8 Suppl), 1668\u20131675.","journal-title":"Cancer"},{"issue":"1","key":"10265_CR181","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00157685","volume":"14","author":"M Yashiro","year":"1996","unstructured":"Yashiro, M., et al. (1996). Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clinical & Experimental Metastasis, 14(1), 43\u201354.","journal-title":"Clinical & Experimental Metastasis"},{"issue":"5","key":"10265_CR182","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/ijc.30801","volume":"141","author":"X Wang","year":"2017","unstructured":"Wang, X., et al. (2017). Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin beta1-FAK signaling pathway. International Journal of Cancer, 141(5), 998\u20131010.","journal-title":"International Journal of Cancer"},{"issue":"12","key":"10265_CR183","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00432-005-0030-3","volume":"131","author":"S Koyama","year":"2005","unstructured":"Koyama, S. (2005). Coordinate cell-surface expression of matrix metalloproteinases and their inhibitors on cancer-associated myofibroblasts from malignant ascites in patients with gastric carcinoma. Journal of Cancer Research and Clinical Oncology, 131(12), 809\u2013814.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"1","key":"10265_CR184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085485","volume":"9","author":"H Yamaguchi","year":"2014","unstructured":"Yamaguchi, H., et al. (2014). Stromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cells. PLoS ONE [Electronic Resource], 9(1), e85485.","journal-title":"PLoS ONE [Electronic Resource]"},{"issue":"Supplement 2","key":"10265_CR185","first-page":"769","volume":"109","author":"S Kuramitsu","year":"2018","unstructured":"Kuramitsu, S., et al. (2018). Significant role of Spondin2 expression in gastric cancer patients with peritoneal dissemination. Cancer Science, 109(Supplement 2), 769.","journal-title":"Cancer Science"},{"issue":"14","key":"10265_CR186","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1158\/1078-0432.CCR-0393-03","volume":"10","author":"H Tanaka","year":"2004","unstructured":"Tanaka, H., et al. (2004). ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma. Clinical Cancer Research, 10(14), 4885\u20134892.","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10265_CR187","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41598-017-19091-2","volume":"8","author":"R Kanamaru","year":"2018","unstructured":"Kanamaru, R., et al. (2018). Low density neutrophils (LDN) in postoperative abdominal cavity assist the peritoneal recurrence through the production of neutrophil extracellular traps (NETs). Scientific reports, 8(1), 632.","journal-title":"Scientific reports"},{"issue":"7","key":"10265_CR188","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1349-7006.2001.tb01157.x","volume":"92","author":"H Nomura","year":"2001","unstructured":"Nomura, H., et al. (2001). A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: Analysis of the mechanism of peritoneal dissemination using cDNA macroarrays. Japanese Journal of Cancer Research, 92(7), 748\u2013754.","journal-title":"Japanese Journal of Cancer Research"},{"issue":"11","key":"10265_CR189","first-page":"13795","volume":"8","author":"C Zhang","year":"2015","unstructured":"Zhang, C., et al. (2015). Effect of tumor-associated macrophages on gastric cancer stem cell in omental milky spots and lymph node micrometastasis. International journal of clinical and experimental pathology, 8(11), 13795\u201313805.","journal-title":"International journal of clinical and experimental pathology"},{"issue":"1","key":"10265_CR190","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10120-020-01092-2","volume":"24","author":"K Gunjigake","year":"2021","unstructured":"Gunjigake, K., et al. (2021). Interleukin-17A derived from mast cells contributes to fibrosis in gastric cancer with peritoneal dissemination. Gastric Cancer, 24(1), 31\u201344.","journal-title":"Gastric Cancer"},{"key":"10265_CR191","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.2147\/CMAR.S318704","volume":"13","author":"Y Fang","year":"2021","unstructured":"Fang, Y., et al. (2021). Comprehensive analysis of peritoneal metastasis sequencing data to identify linc00924 as a prognostic biomarker in gastric cancer. Cancer Management and Research, 13, 5599\u20135611.","journal-title":"Cancer Management and Research"},{"key":"10265_CR192","doi-asserted-by":"crossref","unstructured":"Zhang, C., et al., Immune landscape of gastric carcinoma tumor microenvironment identifies a peritoneal relapse relevant immune signature. Frontiers in Immunology, 2021. 12 (no pagination).","DOI":"10.3389\/fimmu.2021.651033"},{"issue":"5","key":"10265_CR193","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10585-022-10172-9","volume":"39","author":"SU Khan","year":"2022","unstructured":"Khan, S. U., Fatima, K., & Malik, F. (2022). Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis. Clinical & Experimental Metastasis, 39(5), 715\u2013726.","journal-title":"Clinical & Experimental Metastasis"},{"issue":"6","key":"10265_CR194","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/j.bmc.2007.01.011","volume":"15","author":"RP Verma","year":"2007","unstructured":"Verma, R. P., & Hansch, C. (2007). Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs. Bioorganic & Medicinal Chemistry, 15(6), 2223\u20132268.","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"1","key":"10265_CR195","doi-asserted-by":"publisher","first-page":"11499","DOI":"10.1038\/s41598-022-13948-x","volume":"12","author":"D Ng","year":"2022","unstructured":"Ng, D., et al. (2022). Investigating the mechanisms of peritoneal metastasis in gastric adenocarcinoma using a novel ex vivo peritoneal explant model. Science and Reports, 12(1), 11499.","journal-title":"Science and Reports"},{"issue":"7","key":"10265_CR196","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1158\/1535-7163.MCT-21-0860","volume":"21","author":"N Awasthi","year":"2022","unstructured":"Awasthi, N., et al. (2022). Augmenting experimental gastric cancer activity of irinotecan through liposomal formulation and antiangiogenic combination therapy. Molecular Cancer Therapeutics, 21(7), 1149\u20131159.","journal-title":"Molecular Cancer Therapeutics"},{"issue":"4","key":"10265_CR197","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1158\/0008-5472.CAN-05-3393","volume":"66","author":"K Yasumoto","year":"2006","unstructured":"Yasumoto, K., et al. (2006). Role of the CXCL12\/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Research, 66(4), 2181\u20132187.","journal-title":"Cancer Research"},{"issue":"15","key":"10265_CR198","doi-asserted-by":"publisher","first-page":"12132","DOI":"10.1074\/jbc.M111.302299","volume":"287","author":"G Chen","year":"2012","unstructured":"Chen, G., et al. (2012). Inhibition of chemokine (CXC motif) ligand 12\/chemokine (CXC motif) receptor 4 axis (CXCL12\/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells. Journal of Biological Chemistry, 287(15), 12132\u201312141.","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10265_CR199","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ygyno.2021.02.002","volume":"161","author":"KM Sjoquist","year":"2021","unstructured":"Sjoquist, K. M., et al. (2021). REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer. Gynecologic Oncology, 161(2), 374\u2013381.","journal-title":"Gynecologic Oncology"},{"issue":"23","key":"10265_CR200","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.1158\/1078-0432.CCR-14-1071","volume":"20","author":"M Javle","year":"2014","unstructured":"Javle, M., Smyth, E. C., & Chau, I. (2014). Ramucirumab: Successfully targeting angiogenesis in gastric cancer. Clinical Cancer Research, 20(23), 5875\u20135881.","journal-title":"Clinical Cancer Research"},{"key":"10265_CR201","doi-asserted-by":"crossref","unstructured":"Frantsiyants E, K.O., Kaplieva I, Poluektov S, Role of role of angiogenesis factors in formation of metastatic niches. ASCO Annual Meeting 2019.","DOI":"10.1200\/JCO.2019.37.15_suppl.e15534"},{"issue":"6","key":"10265_CR202","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/jso.23116","volume":"106","author":"QM Yu","year":"2012","unstructured":"Yu, Q. M., et al. (2012). CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer. Journal of Surgical Oncology, 106(6), 765\u2013771.","journal-title":"Journal of Surgical Oncology"},{"issue":"3","key":"10265_CR203","doi-asserted-by":"publisher","first-page":"25","DOI":"10.21037\/cco-23-36","volume":"12","author":"SN Gregory","year":"2023","unstructured":"Gregory, S. N., & Davis, J. L. (2023). CDH1 and hereditary diffuse gastric cancer: A narrative review. Chinese Clinical Oncology, 12(3), 25.","journal-title":"Chinese Clinical Oncology"},{"issue":"2","key":"10265_CR204","first-page":"336","volume":"5","author":"K Fukuda","year":"2012","unstructured":"Fukuda, K., et al. (2012). Role of integrin \u03b11 subunits in gastric cancer patients with peritoneal dissemination. Molecular Medicine Reports, 5(2), 336\u2013340.","journal-title":"Molecular Medicine Reports"},{"issue":"17","key":"10265_CR205","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1158\/0008-5472.CAN-04-0321","volume":"64","author":"H Takatsuki","year":"2004","unstructured":"Takatsuki, H., et al. (2004). Adhesion of gastric carcinoma cells to peritoneum mediated by alpha3beta1 integrin (VLA-3). Cancer Research, 64(17), 6065\u20136070.","journal-title":"Cancer Research"},{"key":"10265_CR206","doi-asserted-by":"crossref","unstructured":"Menke-van der Houven van Oordt, C.W., et al., First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors. Oncotarget, 2016. 7(48): p. 80046\u201380058.","DOI":"10.18632\/oncotarget.11098"},{"issue":"3","key":"10265_CR207","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s10120-014-0400-0","volume":"18","author":"CN Chen","year":"2015","unstructured":"Chen, C. N., et al. (2015). Connective tissue growth factor inhibits gastric cancer peritoneal metastasis by blocking integrin \u03b13\u03b21-dependent adhesion. Gastric Cancer, 18(3), 504\u2013515.","journal-title":"Gastric Cancer"},{"issue":"11","key":"10265_CR208","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1161\/01.ATV.17.11.2568","volume":"17","author":"M Braun","year":"1997","unstructured":"Braun, M., et al. (1997). Regulation of tumor necrosis factor alpha- and interleukin-1-beta-induced induced adhesion molecule expression in human vascular smooth muscle cells by cAMP. Arteriosclerosis, Thrombosis, and Vascular Biology, 17(11), 2568\u20132575.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10265_CR209","doi-asserted-by":"publisher","first-page":"107994","DOI":"10.1016\/j.pharmthera.2021.107994","volume":"232","author":"F Aziz","year":"2022","unstructured":"Aziz, F., et al. (2022). Partners in crime: The Lewis Y antigen and fucosyltransferase IV in Helicobacter pylori-induced gastric cancer. Pharmacology & Therapeutics, 232, 107994.","journal-title":"Pharmacology & Therapeutics"},{"issue":"4","key":"10265_CR210","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/01.mpa.0000220865.80034.2a","volume":"32","author":"WM van Grevenstein","year":"2006","unstructured":"van Grevenstein, W. M., et al. (2006). The expression of adhesion molecules and the influence of inflammatory cytokines on the adhesion of human pancreatic carcinoma cells to mesothelial monolayers. Pancreas, 32(4), 396\u2013402.","journal-title":"Pancreas"},{"issue":"1","key":"10265_CR211","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1756-9966-29-139","volume":"29","author":"ZD Lv","year":"2010","unstructured":"Lv, Z. D., et al. (2010). Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis. Journal of Experimental & Clinical Cancer Research, 29(1), 139.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"2","key":"10265_CR212","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3892\/or.2014.3636","volume":"33","author":"T Shinbo","year":"2015","unstructured":"Shinbo, T., et al. (2015). Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-\u03b2 signaling pathway. Oncology Reports, 33(2), 553\u2013558.","journal-title":"Oncology Reports"},{"issue":"29","key":"10265_CR213","doi-asserted-by":"publisher","first-page":"e29632","DOI":"10.1097\/MD.0000000000029632","volume":"101","author":"TY Wang","year":"2022","unstructured":"Wang, T. Y., et al. (2022). Protein-bound polysaccharide K prolonged overall survival in gastric cancer patients from a non-Japanese Asian country who received gastrectomy and adjuvant chemotherapy. Medicine (Baltimore), 101(29), e29632.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10265_CR214","first-page":"3427","volume":"32","author":"H Tanaka","year":"2012","unstructured":"Tanaka, H., et al. (2012). Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer. Anticancer Research, 32(8), 3427\u20133433.","journal-title":"Anticancer Research"},{"key":"10265_CR215","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.2147\/IJN.S272378","volume":"15","author":"VC Kok","year":"2020","unstructured":"Kok, V. C., & Yu, C. C. (2020). Cancer-derived exosomes: Their role in cancer biology and biomarker development. International Journal of Nanomedicine, 15, 8019\u20138036.","journal-title":"International Journal of Nanomedicine"},{"issue":"5","key":"10265_CR216","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3892\/ijo.2013.2068","volume":"43","author":"S Miyake","year":"2013","unstructured":"Miyake, S., et al. (2013). HIF-1\u03b1 is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer. International Journal of Oncology, 43(5), 1431\u20131440.","journal-title":"International Journal of Oncology"},{"issue":"1","key":"10265_CR217","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4149\/neo_2011_01_20","volume":"58","author":"L Cao","year":"2011","unstructured":"Cao, L., et al. (2011). Omental milky spots in screening gastric cancer stem cells. Neoplasma, 58(1), 20\u201326.","journal-title":"Neoplasma"},{"issue":"12","key":"10265_CR218","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1002\/stem.1816","volume":"32","author":"ZF Miao","year":"2014","unstructured":"Miao, Z. F., et al. (2014). Peritoneal milky spots serve as a hypoxic niche and favor gastric cancer stem\/progenitor cell peritoneal dissemination through hypoxia-inducible factor 1\u03b1. Stem Cells, 32(12), 3062\u20133074.","journal-title":"Stem Cells"},{"key":"10265_CR219","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semcancer.2013.12.008","volume":"25","author":"A Calon","year":"2014","unstructured":"Calon, A., Tauriello, D. V., & Batlle, E. (2014). TGF-beta in CAF-mediated tumor growth and metastasis. Seminars in Cancer Biology, 25, 15\u201322.","journal-title":"Seminars in Cancer Biology"},{"issue":"4","key":"10265_CR220","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s10120-015-0579-8","volume":"19","author":"T Yamaguchi","year":"2016","unstructured":"Yamaguchi, T., et al. (2016). Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination. Gastric Cancer, 19(4), 1052\u20131065.","journal-title":"Gastric Cancer"},{"issue":"1","key":"10265_CR221","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1186\/s12885-020-07477-x","volume":"20","author":"D Fujimori","year":"2020","unstructured":"Fujimori, D., et al. (2020). Established fibrous peritoneal metastasis in an immunocompetent mouse model similar to clinical immune microenvironment of gastric cancer. BMC Cancer, 20(1), 1014.","journal-title":"BMC Cancer"},{"issue":"22","key":"10265_CR222","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.7150\/jca.31787","volume":"10","author":"H Song","year":"2019","unstructured":"Song, H., et al. (2019). Macrophages on the peritoneum are involved in gastric cancer peritoneal metastasis. Journal of Cancer, 10(22), 5377\u20135387.","journal-title":"Journal of Cancer"},{"key":"10265_CR223","doi-asserted-by":"crossref","unstructured":"Kanamaru, R., et al., Neutrophil extracellular traps generated by low density neutrophils obtained from peritoneal lavage fluid mediate tumor cell growth and attachment. J Vis Exp, 2018(138).","DOI":"10.3791\/58201-v"},{"issue":"8","key":"10265_CR224","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1158\/1078-0432.CCR-20-3835","volume":"27","author":"IS Lee","year":"2021","unstructured":"Lee, I. S., et al. (2021). Transcriptomic profiling identifies a risk stratification signature for predicting peritoneal recurrence and micrometastasis in gastric cancer. Clinical Cancer Research, 27(8), 2292\u20132300.","journal-title":"Clinical Cancer Research"},{"key":"10265_CR225","doi-asserted-by":"publisher","first-page":"101416","DOI":"10.1016\/j.molmet.2021.101416","volume":"55","author":"Y Higuchi","year":"2022","unstructured":"Higuchi, Y., et al. (2022). Requirement of Cavin-2 for the expression and stability of IR\u03b2 in adequate adipocyte differentiation. Mol Metab, 55, 101416.","journal-title":"Mol Metab"},{"issue":"3","key":"10265_CR226","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen, I., et al. (2014). Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors. International Journal of Cancer, 134(3), 622\u2013628.","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10265_CR227","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jso.24087","volume":"113","author":"H Shiozaki","year":"2016","unstructured":"Shiozaki, H., et al. (2016). Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases. Journal of Surgical Oncology, 113(1), 29\u201335.","journal-title":"Journal of Surgical Oncology"},{"issue":"4","key":"10265_CR228","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jamcollsurg.2014.03.062","volume":"219","author":"G Spolverato","year":"2014","unstructured":"Spolverato, G., et al. (2014). Rates and patterns of recurrence after curative intent resection for gastric cancer: A United States multi-institutional analysis. Journal of the American College of Surgeons, 219(4), 664\u2013675.","journal-title":"Journal of the American College of Surgeons"},{"issue":"9","key":"10265_CR229","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1245\/s10434-017-5838-y","volume":"24","author":"N Ikoma","year":"2017","unstructured":"Ikoma, N., et al. (2017). Patterns of initial recurrence in gastric adenocarcinoma in the era of preoperative therapy. Annals of Surgical Oncology, 24(9), 2679\u20132687.","journal-title":"Annals of Surgical Oncology"},{"issue":"2","key":"10265_CR230","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00595-009-4251-y","volume":"41","author":"J Deng","year":"2011","unstructured":"Deng, J., et al. (2011). Investigation of the recurrence patterns of gastric cancer following a curative resection. Surgery Today, 41(2), 210\u2013215.","journal-title":"Surgery Today"},{"issue":"1","key":"10265_CR231","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa073149","volume":"358","author":"D Cunningham","year":"2008","unstructured":"Cunningham, D., et al. (2008). Capecitabine and oxaliplatin for advanced esophagogastric cancer. New England Journal of Medicine, 358(1), 36\u201346.","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10265_CR232","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","volume":"9","author":"W Koizumi","year":"2008","unstructured":"Koizumi, W., et al. (2008). S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial. The lancet Oncology, 9(3), 215\u2013221.","journal-title":"The lancet Oncology"},{"issue":"9","key":"10265_CR233","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.2009.25.4706","volume":"28","author":"JA Ajani","year":"2010","unstructured":"Ajani, J. A., et al. (2010). Multicenter phase III comparison of cisplatin\/S-1 with cisplatin\/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: The FLAGS trial. Journal of Clinical Oncology, 28(9), 1547\u20131553.","journal-title":"Journal of Clinical Oncology"},{"issue":"9911","key":"10265_CR234","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","volume":"383","author":"CS Fuchs","year":"2014","unstructured":"Fuchs, C. S., et al. (2014). Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): An international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet, 383(9911), 31\u201339.","journal-title":"Lancet"},{"issue":"9742","key":"10265_CR235","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang, Y. J., et al. (2010). Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial. Lancet, 376(9742), 687\u2013697.","journal-title":"Lancet"},{"key":"10265_CR236","doi-asserted-by":"crossref","unstructured":"Shah, M.A., et al., Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: The randomized, phase 3 GLOW trial. Nat Med, 2023. 29(8): p. 2133\u20132141.","DOI":"10.1038\/s41591-023-02465-7"},{"key":"10265_CR237","doi-asserted-by":"crossref","unstructured":"Shitara, K., et al., Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): A multicentre, randomised, double-blind, phase 3 trial. Lancet, 2023. 401(10389): p. 1655\u20131668.","DOI":"10.1016\/S0140-6736(23)00620-7"},{"issue":"10","key":"10265_CR238","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","volume":"6","author":"K Shitara","year":"2020","unstructured":"Shitara, K., et al. (2020). Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: The KEYNOTE-062 phase 3 randomized clinical trial. JAMA Oncology, 6(10), 1571\u20131580.","journal-title":"JAMA Oncology"},{"issue":"10294","key":"10265_CR239","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian, Y. Y., et al. (2021). First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): A randomised, open-label, phase 3 trial. Lancet, 398(10294), 27\u201340.","journal-title":"Lancet"},{"key":"10265_CR240","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12885-015-1081-8","volume":"15","author":"F Seyfried","year":"2015","unstructured":"Seyfried, F., et al. (2015). Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin\u2013A longitudinal experience from a prospectively collected database of 1108 patients. BMC Cancer, 15, 73.","journal-title":"BMC Cancer"},{"issue":"9688","key":"10265_CR241","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0140-6736(09)60617-6","volume":"374","author":"HH Hartgrink","year":"2009","unstructured":"Hartgrink, H. H., et al. (2009). Gastric cancer. Lancet, 374(9688), 477\u2013490.","journal-title":"Lancet"},{"issue":"6","key":"10265_CR242","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1245\/s10434-016-5102-x","volume":"23","author":"M Kanda","year":"2016","unstructured":"Kanda, M., et al. (2016). Tumor infiltrative pattern predicts sites of recurrence after curative gastrectomy for stages 2 and 3 gastric cancer. Annals of Surgical Oncology, 23(6), 1934\u20131940.","journal-title":"Annals of Surgical Oncology"},{"issue":"11","key":"10265_CR243","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrclinonc.2013.170","volume":"10","author":"R Wadhwa","year":"2013","unstructured":"Wadhwa, R., et al. (2013). Gastric cancer-molecular and clinical dimensions. Nature Reviews. Clinical Oncology, 10(11), 643\u2013655.","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"10265_CR244","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-4613-1247-5_4","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet, P., & Sugarbaker, P. H. (1996). Peritoneal-plasma barrier. Cancer Treatment and Research, 82, 53\u201363.","journal-title":"Cancer Treatment and Research"},{"issue":"2","key":"10265_CR245","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi, B., et al. (2000). Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer, 88(2), 358\u2013363.","journal-title":"Cancer"},{"issue":"11","key":"10265_CR246","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","volume":"15","author":"H Wilke","year":"2014","unstructured":"Wilke, H., et al. (2014). Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): A double-blind, randomised phase 3 trial. The lancet Oncology, 15(11), 1224\u20131235.","journal-title":"The lancet Oncology"},{"issue":"11","key":"10265_CR247","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/S1470-2045(18)30739-3","volume":"19","author":"K Shitara","year":"2018","unstructured":"Shitara, K., et al. (2018). Trifluridine\/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): A randomised, double-blind, placebo-controlled, phase 3 trial. The lancet Oncology, 19(11), 1437\u20131448.","journal-title":"The lancet Oncology"},{"issue":"10111","key":"10265_CR248","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","volume":"390","author":"YK Kang","year":"2017","unstructured":"Kang, Y. K., et al. (2017). Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 390(10111), 2461\u20132471.","journal-title":"Lancet"},{"key":"10265_CR249","doi-asserted-by":"crossref","unstructured":"Hideyuki Ohzawa, M.M., Rei Takahashi, Kohei Tamura, Yuki Kaneko, Yurie Futoh, Rie Kawashima, Hideyo Miyato, Naohiro Sata, Joji Kitayama, Expression of claudin 18.2 in peritoneal metastasis (PM) of gastric cancer. Journal of Clinical Oncology 2024 42:3_suppl, 403\u2013403.","DOI":"10.1200\/JCO.2024.42.3_suppl.403"},{"issue":"23","key":"10265_CR250","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot, P. E., et al. (2019). Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): A propensity score analysis. Journal of Clinical Oncology, 37(23), 2028\u20132040.","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10265_CR251","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang, X. J., et al. (2011). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: Final results of a phase III randomized clinical trial. Annals of Surgical Oncology, 18(6), 1575\u20131581.","journal-title":"Annals of Surgical Oncology"},{"issue":"3","key":"10265_CR252","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff, U., et al. (2014). Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial. Journal of Surgical Oncology, 110(3), 275\u2013284.","journal-title":"Journal of Surgical Oncology"},{"issue":"2","key":"10265_CR253","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1200\/JCO.22.02867","volume":"42","author":"B Rau","year":"2024","unstructured":"Rau, B., et al. (2024). Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: The phase III GASTRIPEC-I trial. Journal of Clinical Oncology, 42(2), 146\u2013156.","journal-title":"Journal of Clinical Oncology"},{"key":"10265_CR254","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","volume":"79","author":"J Desiderio","year":"2017","unstructured":"Desiderio, J., et al. (2017). The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. European Journal of Cancer, 79, 1\u201314.","journal-title":"European Journal of Cancer"},{"issue":"2","key":"10265_CR255","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ags3.12060","volume":"2","author":"J Kitayama","year":"2018","unstructured":"Kitayama, J., et al. (2018). Treatment of patients with peritoneal metastases from gastric cancer. Ann Gastroenterol Surg, 2(2), 116\u2013123.","journal-title":"Ann Gastroenterol Surg"},{"issue":"19","key":"10265_CR256","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","volume":"36","author":"H Ishigami","year":"2018","unstructured":"Ishigami, H., et al. (2018). Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial. Journal of Clinical Oncology, 36(19), 1922\u20131929.","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10265_CR257","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1245\/s10434-013-3208-y","volume":"21","author":"J Kitayama","year":"2014","unstructured":"Kitayama, J., et al. (2014). Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. Annals of Surgical Oncology, 21(2), 539\u2013546.","journal-title":"Annals of Surgical Oncology"},{"key":"10265_CR258","doi-asserted-by":"crossref","unstructured":"Chan, D.Y., et al., Conversion Surgery post-intraperitoneal paclitaxel and systemic chemotherapy for gastric cancer carcinomatosis peritonei. Are we ready? J Gastrointest Surg, 2017. 21(3): p. 425\u2013433.","DOI":"10.1007\/s11605-016-3336-3"},{"issue":"Suppl 1","key":"10265_CR259","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s10120-016-0684-3","volume":"20","author":"H Ishigami","year":"2017","unstructured":"Ishigami, H., et al. (2017). Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings. Gastric Cancer, 20(Suppl 1), 128\u2013134.","journal-title":"Gastric Cancer"},{"issue":"2","key":"10265_CR260","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U","volume":"61","author":"S Koga","year":"1988","unstructured":"Koga, S., et al. (1988). Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer, 61(2), 232\u2013237.","journal-title":"Cancer"},{"key":"10265_CR261","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1471-2407-14-183","volume":"14","author":"O Glehen","year":"2014","unstructured":"Glehen, O., et al. (2014). GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: A randomized and multicenter phase III study. BMC Cancer, 14, 183.","journal-title":"BMC Cancer"},{"key":"10265_CR262","doi-asserted-by":"crossref","unstructured":"Marano, L., et al., Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with synchronous peritoneal metastases: Multicenter study of \u2018Italian peritoneal surface malignancies oncoteam-S.I.C.O.\u2019. Ann Surg Oncol, 2021. 28(13): p. 9060\u20139070.","DOI":"10.1245\/s10434-021-10157-0"},{"key":"10265_CR263","doi-asserted-by":"crossref","unstructured":"Di Giorgio, A., et al., 10 years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): A systematic review and meta-analysis. Cancers (Basel), 2023. 15(4).","DOI":"10.3390\/cancers15041125"},{"issue":"18","key":"10265_CR264","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1158\/1078-0432.CCR-18-0244","volume":"24","author":"UM Lauer","year":"2018","unstructured":"Lauer, U. M., et al. (2018). Phase I study of oncolytic vaccinia virus GL-ONC1 in patients with peritoneal carcinomatosis. Clinical Cancer Research, 24(18), 4388\u20134398.","journal-title":"Clinical Cancer Research"},{"key":"10265_CR265","doi-asserted-by":"crossref","unstructured":"Qi, C., et al., Claudin18.2-specific CAR T cells in gastrointestinal cancers: Phase 1 trial interim results. Nat Med, 2022. 28(6): p. 1189\u20131198.","DOI":"10.1038\/s41591-022-01800-8"},{"key":"10265_CR266","doi-asserted-by":"crossref","unstructured":"Archid, R., et al., shRNA-mediated inhibition of phosphoglycerate kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin. Eur J Surg Oncol, 2020. 46(4 Pt A): p. 613\u2013619.","DOI":"10.1016\/j.ejso.2020.01.018"},{"key":"10265_CR267","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.biopha.2015.03.005","volume":"71","author":"FT Shang","year":"2015","unstructured":"Shang, F. T., et al. (2015). ZnPPIX inhibits peritoneal metastasis of gastric cancer via its antiangiogenic activity. Biomedicine & Pharmacotherapy, 71, 240\u2013246.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10265_CR268","doi-asserted-by":"crossref","unstructured":"Manzanedo, I., et al., Gastric cancer with peritoneal metastases: Current status and prospects for treatment. Cancers (Basel), 2023. 15(6).","DOI":"10.3390\/cancers15061777"},{"key":"10265_CR269","doi-asserted-by":"publisher","first-page":"864647","DOI":"10.3389\/fonc.2022.864647","volume":"12","author":"A Prabhu","year":"2022","unstructured":"Prabhu, A., et al. (2022). Gastric cancer with peritoneal metastasis-A comprehensive review of current intraperitoneal treatment modalities. Frontiers in Oncology, 12, 864647.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10265_CR270","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41467-023-36310-9","volume":"14","author":"XZ Huang","year":"2023","unstructured":"Huang, X. Z., et al. (2023). Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis. Nature Communications, 14(1), 822.","journal-title":"Nature Communications"},{"issue":"6","key":"10265_CR271","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/jso.27987","volume":"130","author":"S G\u00fcl","year":"2024","unstructured":"G\u00fcl, S., et al. (2024). Emerging treatment modalities for gastric cancer with macroscopic peritoneal metastases: A systematic review. Journal of Surgical Oncology, 130(6), 1364\u20131377.","journal-title":"Journal of Surgical Oncology"},{"issue":"4","key":"10265_CR272","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/145749690609500410","volume":"95","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker, P. H. (2006). Adjuvant intraperitoneal chemotherapy for advanced primary gastric cancer. Scand J Surg, 95(4), 270\u2013273.","journal-title":"Scand J Surg"},{"key":"10265_CR273","doi-asserted-by":"crossref","unstructured":"Coccolini, F., et al., Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials. Eur J Surg Oncol, 2014. 40(1): p. 12\u201326.","DOI":"10.1016\/j.ejso.2013.10.019"},{"key":"10265_CR274","unstructured":"Gupta, P., Rodriguez, M., & Thompson, E, Novel intraperitoneal delivery strategies for immunomodulatory agents: From PIPAC to combination therapies. Clinical Cancer Research 2022, 28(15), 3205\u20133213."},{"key":"10265_CR275","unstructured":"Chen, L., Kim, S., & Martinez, R, STING agonists in cancer therapy: Preclinical studies and early clinical insights. . Cancer Immunology Research 2022, 10(3), 305\u2013312."},{"issue":"1","key":"10265_CR276","doi-asserted-by":"publisher","first-page":"200767","DOI":"10.1016\/j.omton.2024.200767","volume":"32","author":"A Sikora","year":"2024","unstructured":"Sikora, A., et al. (2024). Emerging therapeutic approaches for peritoneal metastases from gastrointestinal cancers. Mol Ther Oncol, 32(1), 200767.","journal-title":"Mol Ther Oncol"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10265-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-025-10265-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10265-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T06:03:31Z","timestamp":1751004211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-025-10265-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":276,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["10265"],"URL":"https:\/\/doi.org\/10.1007\/s10555-025-10265-3","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"50"}}